Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

XENE Xenon Pharmaceuticals Inc

38,37

-0,09 (-0,23%)

25 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Xenon Pharmaceuticals (NASDAQ:XENE)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Xenon Pharmaceuticals Charts.

Xenon Pharmaceuticals (NASDAQ:XENE)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Xenon Pharmaceuticals Charts.

News Xenon Pharmaceuticals Inc

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 9 Mai 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 9 Mai 2024 (2 Wochen vor) • Edgar (US Regulatory)

Xenon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
Donnerstag 9 Mai 2024 (2 Wochen vor) • GlobeNewswire Inc.

Xenon Pharmaceuticals to Present at the BofA Securities Health Care Conference 2024
Mittwoch 8 Mai 2024 (3 Wochen vor) • GlobeNewswire Inc.

Xenon Pharmaceuticals to Present at the 2024 RBC Capital Markets Global Healthcare Conference
Dienstag 7 Mai 2024 (3 Wochen vor) • GlobeNewswire Inc.

Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Corporate Update
Donnerstag 2 Mai 2024 (3 Wochen vor) • GlobeNewswire Inc.

Xenon Pharmaceuticals Showcases XEN1101 at the American Academy of Neurology 2024 Annual Meeting
Dienstag 16 April 2024 (1 Monat vor) • GlobeNewswire Inc.

Xenon Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference
Donnerstag 4 April 2024 (2 Monate vor) • GlobeNewswire Inc.

Xenon Pharmaceuticals to Present at Stifel 2024 Virtual CNS Days
Dienstag 12 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 144 - Report of proposed sale of securities
Samstag 9 März 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 8 März 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 8 März 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere Xenon Pharmaceuticals Inc News-Artikel

SG Issuer Sg Issuer Mc D...

Db X Trackers Ii iboxx S...

Abound Energy (PK)

Seine and Marne Departme...

Chow Tai Fook Jewellery (PK)

Marret High Yield Strate... (GM)

SG Issuer Sg Issuer Mc F...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen